Ritonavir News and Research

RSS
Ritonavir, also known as Norvir, is a type of medicine called a protease inhibitor (PI). PIs act by blocking protease, a protein that HIV needs to make more copies of itself. Ritonavir was approved by the FDA on March 1, 1996, for use with other antiretroviral agents in the treatment of HIV infection in adults and children 2 years of age or older. Ritonavir is now approved with other anti-HIV drugs in the treatment of HIV-1 infection in children in individuals over 1 month in age. Studies have shown that ritonavir works as a booster for some other PIs. Taking ritonavir makes it possible to take a lower dose of the other PIs. This medicine does not cure or prevent HIV infection or AIDS and does not reduce the risk of passing the virus to other people.
Study shows consistent efficacy of Paxlovid regardless of age, number of vaccinations, comorbidities

Study shows consistent efficacy of Paxlovid regardless of age, number of vaccinations, comorbidities

Influenza hospitalizations at highest level in ten years, predicting a severe U.S. flu season

Influenza hospitalizations at highest level in ten years, predicting a severe U.S. flu season

What is the role of cyclophilin-A in alleviating SARS-CoV-2 infections?

What is the role of cyclophilin-A in alleviating SARS-CoV-2 infections?

Cohort study determines how often COVID-19 symptoms recurred

Cohort study determines how often COVID-19 symptoms recurred

How does COVID-19 and its treatment affect testicular function?

How does COVID-19 and its treatment affect testicular function?

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Transition in the management of COVID-19

Transition in the management of COVID-19

In silico studies identify potent plant metabolites capable of inhibiting SARS-CoV-2

In silico studies identify potent plant metabolites capable of inhibiting SARS-CoV-2

What is the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant?

What is the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant?

Observational study explores the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant

Observational study explores the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients

Are men or women impacted more by adverse reactions to prescription drug treatments?

Are men or women impacted more by adverse reactions to prescription drug treatments?

What is the association of SARS-CoV-2 vaccination with the risk of PASC in patients with SARDs?

What is the association of SARS-CoV-2 vaccination with the risk of PASC in patients with SARDs?

Chronic liver disease in COVID-19 patients

Chronic liver disease in COVID-19 patients

Acute kidney injury in hospitalized COVID-19 patients

Acute kidney injury in hospitalized COVID-19 patients

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

Study finds remdesivir-resistant version of COVID-19 in renal transplant recipients

Study finds remdesivir-resistant version of COVID-19 in renal transplant recipients

Antibody drugs are not recommended for patients with covid-19, say WHO experts

Antibody drugs are not recommended for patients with covid-19, say WHO experts

Efficacy and safety of monoclonal antibodies against SARS-CoV-2 during pregnancy

Efficacy and safety of monoclonal antibodies against SARS-CoV-2 during pregnancy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.